Stockscreener 앱 받기
47.57
1.67%
-0.81
전일 마감가:
$48.38
열려 있는:
$48.2
하루 거래량:
1.95M
Relative Volume:
1.59
시가총액:
$9.80B
수익:
$2.04B
순이익/손실:
$373.39M
주가수익비율:
28.05
EPS:
1.6961
순현금흐름:
$495.96M
1주 성능:
-1.49%
1개월 성능:
+5.69%
6개월 성능:
-1.51%
1년 성능:
+0.76%
1일 변동 폭
$47.21
$48.40
1주일 범위
$46.41
$48.59
52주 변동 폭
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
QGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
47.57 | 9.97B | 2.04B | 373.39M | 495.96M | 1.6961 |
|
TMO
Thermo Fisher Scientific Inc
|
618.72 | 234.69B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.99 | 169.45B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
715.37 | 56.86B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
237.68 | 41.09B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
139.64 | 41.06B | 6.95B | 1.30B | 1.15B | 4.5696 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-06-24 | 개시 | Barclays | Overweight |
| 2025-04-04 | 다운그레이드 | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-10-17 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-06-27 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-12-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-12 | 개시 | Robert W. Baird | Outperform |
| 2023-05-23 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-01-18 | 업그레이드 | DZ Bank | Hold → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-10-14 | 개시 | Redburn | Buy |
| 2021-07-14 | 다운그레이드 | Kepler | Buy → Hold |
| 2021-06-03 | 개시 | Goldman | Neutral |
| 2020-10-06 | 재개 | BofA Securities | Buy |
| 2020-09-28 | 업그레이드 | Kepler | Hold → Buy |
| 2020-08-24 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-08-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-08-14 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-12-26 | 재개 | BofA/Merrill | Underperform |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-11-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-11-14 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2019-11-14 | 업그레이드 | Kepler | Reduce → Hold |
| 2019-10-17 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | 다운그레이드 | Kepler | Hold → Reduce |
| 2019-10-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-10-08 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
모두보기
Qiagen Nv 주식(QGEN)의 최신 뉴스
Qiagen N.V. $QGEN Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Sumitomo Mitsui Trust Group Inc. Invests $7.29 Million in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. (NYSE:QGEN) Short Interest Down 20.2% in December - MarketBeat
Campbell & CO Investment Adviser LLC Makes New Investment in Qiagen N.V. $QGEN - MarketBeat
Analysis Recap: Is Qiagen NV stock a smart retirement pickJuly 2025 Earnings & Safe Capital Investment Plans - baoquankhu1.vn
Massachusetts Financial Services Discloses Nearly 10% Voting Stake in Qiagen - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView — Track All Markets
Release according to Article 40, Section 1 of the WpHG - TradingView — Track All Markets
QIAGEN NV : Receives a Buy rating from DZ Bank - marketscreener.com
Qiagen N.V.: How a Quiet Diagnostics Powerhouse Became a Platform Bet on the Future of Medicine - AD HOC NEWS
Qiagen and Gencurix partner for oncology tests - MSN
Did Qiagen’s (QGEN) AI and Automation Push Just Redefine Its Diagnostics Investment Narrative? - simplywall.st
JPM26: Qiagen outlines key priorities to drive momentum in 2026 - Medical Device Network
Canada Next-Generation Sequencing (NGS) Market Analysis and Forecast, 2025-2035, Featuring Illumina, Oxford Nanopore Technologies, Pacific Bioscience of California, MGI Tech Co., QIAGEN and More - GlobeNewswire
Aug Momentum: How Qiagen NV stock performs in interest rate cycles2025 Big Picture & High Accuracy Swing Entry Alerts - Bộ Nội Vụ
QIAGEN Board Member’s Holdings Adjusted Following Share Consolidation - TipRanks
QIAGEN Adjusts Management Shareholdings Following Synthetic Share Repurchase - TipRanks
QIAGEN Adjusts Board Member Shareholding Following Synthetic Share Consolidation - TipRanks
QIAGEN discloses management share consolidation under synthetic repurchase program - TipRanks
QIAGEN adjusts insider shareholdings after synthetic share repurchase and consolidation - TipRanks
QIAGEN adjusts board member shareholding after synthetic share consolidation - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView — Track All Markets
Qiagen N.V.: Diagnostics Specialist Tests Investor Patience Amid Sideways Trading and Selective Opti - AD HOC NEWS
Qiagen (QGEN) is a Top-Ranked Momentum Stock: Should You Buy? - Yahoo Finance
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth - BioSpace
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Soli - PharmiWeb.com
Qiagen sets 2026 priorities to drive growth - marketscreener.com
Qiagen N.V.: How a Quiet Diagnostics Powerhouse Became a Genomics Infrastructure Play - AD HOC NEWS
Published on: 2026-01-10 23:18:15 - ulpravda.ru
Qiagen (NYSE:QGEN) Stock Rating Lowered by Wall Street Zen - MarketBeat
Qiagen N.V.: How a Quiet Workflow Powerhouse Is Shaping the Future of Molecular Diagnostics - AD HOC NEWS
Qiagen N : announces adjustment of conversion price under its US$ 500,000,000 Convertible Bonds due 2031 - marketscreener.com
Qiagen N : announces adjustment of conversion price under its US$ 500,000,000 Convertible Bonds due 2027 - marketscreener.com
Will Qiagen N.V. stock recover faster than peersStock Surge & Low Risk Profit Maximizing Plans - Улправда
Does Qiagen N.V. (QGEN) Have Momentum? - AAII
Why Qiagen N.V. Common Shares stock trades below fair valueJuly 2025 Spike Watch & Reliable Breakout Forecasts - Улправда
Is Qiagen N.V. stock in correction or buying zoneWeekly Trading Summary & Daily Volume Surge Signals - Улправда
Will Qiagen N.V. (QIA) stock outperform value peersWeekly Profit Recap & Detailed Earnings Play Strategies - Улправда
Qiagen NV To Carry Out 19-for-20 Reverse Stock Split On January 8th, 2026 - 富途牛牛
How Qiagen N.V. stock valuations compare to rivalsMarket Volume Summary & Risk Controlled Daily Trade Plans - Улправда
Insiders At Qiagen Sold US$3.7m In Stock, Alluding To Potential Weakness - 富途牛牛
Sectors Review: How buybacks impact Qiagen N.V. stock valueWeekly Profit Recap & High Conviction Investment Ideas - Улправда
PTA-NVR: QIAGEN N.V.: Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView — Track All Markets
Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView — Track All Markets
Qiagen NV To Go Ex-Dividend On January 8th, 2026 With 2.29 USD Dividend Per Share And 19-for-20 Reverse Stock Split - 富途牛牛
Fivespan Said to Build Stake in Life Sciences Group Qiagen - MSN
Gateway Investment Advisers LLC Takes Position in Qiagen N.V. $QGEN - MarketBeat
Citi Maintains Qiagen NV(QGEN.US) With Hold Rating - 富途牛牛
Qiagen N.V. (QGEN) Stock Analysis: Navigating a 11.91% Potential Upside in Healthcare Diagnostics - DirectorsTalk Interviews
Generali Asset Management SPA SGR Increases Holdings in Qiagen N.V. $QGEN - MarketBeat
Weekly Trades: Why Qiagen NV Common Shares stock trades below fair valueJuly 2025 Momentum & Low Risk High Win Rate Stock Picks - moha.gov.vn
Qiagen Nv (QGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.51%
0.74%
자본화:
|
볼륨(24시간):